Aly Karsan

St. Paul's Hospital
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications

Alternatively spliced MBD1 in MDS: the long and short of it.

Alternatively spliced MBD1 in MDS: the long and short of it.

Journal: Blood
Published: August 27, 2026

EpiATLAS - a reference for human epigenomic research.

EpiATLAS - a reference for human epigenomic research.

Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Journal: Blood advances
Published: February 13, 2026

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

Journal: Journal of pathology informatics
Published: December 24, 2025

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 01, 2025

SRSF2-mutated MDS: bortezomib STAT?

SRSF2-mutated MDS: bortezomib STAT?

Journal: Blood
Published: July 03, 2025

Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes.

Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes.

Journal: Blood neoplasia
Published: May 06, 2025

Initial leukemic epigenomic state determines hypomethylating agent response.

Initial leukemic epigenomic state determines hypomethylating agent response.

Journal: Nature communications
Published: April 29, 2025

Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Journal: JCO precision oncology
Published: April 23, 2025

Validation of a Modular Gene Expression Assay for Risk Stratification and Subtyping Lymphomas.

Validation of a Modular Gene Expression Assay for Risk Stratification and Subtyping Lymphomas.

Journal: The Journal of molecular diagnostics : JMD
Published: April 17, 2025

Patient and population impacts of multigene panel and pembrolizumab coverage in metastatic melanoma.

Patient and population impacts of multigene panel and pembrolizumab coverage in metastatic melanoma.

Journal: Journal of the National Cancer Institute
Published: March 24, 2025

Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanoma.

Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanoma.

Journal: Journal of the National Cancer Institute
Published: March 24, 2025
Showing 1-12 of 154

Last Updated: 09/26/2026